Medtronic plc (LON:0Y6X)
London
· Delayed Price · Currency is GBP · Price in USD | Market Cap | 79.92B |
| Revenue (ttm) | 26.58B |
| Net Income (ttm) | 3.41B |
| Shares Out | n/a |
| EPS (ttm) | 2.62 |
| PE Ratio | 23.43 |
| Forward PE | n/a |
| Dividend | 2.17 (2.63%) |
| Ex-Dividend Date | Mar 28, 2025 |
| Volume | 8,012 |
| Average Volume | 5,090 |
| Open | 81.50 |
| Previous Close | 83.18 |
| Day's Range | 81.50 - 83.18 |
| 52-Week Range | 68.87 - 91.91 |
| Beta | 0.81 |
| RSI | 36.64 |
| Earnings Date | May 21, 2025 |
About Medtronic
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. The Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accesso... [Read more]
Financial Performance
In 2024, Medtronic's revenue was $32.36 billion, an increase of 3.64% compared to the previous year's $31.23 billion. Earnings were $3.68 billion, a decrease of -2.18%.
Financial numbers in USD Financial StatementsNews
The Best Large-Cap Stocks to Buy
Large-cap stocks are key additions to any well-rounded portfolio, but how do you find the best ones? We take a closer look here.
Looking Into Medtronic's Recent Short Interest
Medtronic's (NYSE: MDT) short percent of float has fallen 4.76% since its last report. The company recently reported that it has 12.83 million shares sold short , which is 1.0% of all regular shares ...
'MythBusters' star Adam Savage explores longevity and life hacks: 'There's no magic secret'
Adam Savage of "MythBusters" sat down with Fox News Digital to explore the science of healthy and longer lives after forming a new partnership with Medtronic.
Medtronic (MDT) Stock Climbs on Promising Evolut TAVR Data
Medtronic (MDT) Stock Climbs on Promising Evolut TAVR Data
Why Medtronic Stock Marched Higher on Monday
Best Dividend Aristocrats For April 2025
Dividend Aristocrats are outperforming the S&P 500 in 2025, demonstrating resilience, with NOBL up 1.78% YTD versus SPY's 4.9% decline. Top performers include Consolidated Edison (+22.98%), Brown & Br...
Medtronic Evolut™ TAVR system shows durable clinical outcomes and outstanding valve performance at five years in low-risk aortic stenosis patients
GALWAY, Ireland and CHICAGO , March 30, 2025 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced late-breaking data on five-year outcomes from the Evol...
Prediction: Buying Medtronic Today Will Set You Up for Life
Intel Board Shake-Up Continues As Three Directors Exit Amid Leadership Overhaul Under CEO Lip-Bu Tan
Intel Corporation (NASDAQ: INTC) is undergoing another wave of leadership changes as three board members prepare to step down, signaling a continued shift in strategy under newly appointed CEO Lip-Bu...
Medtronic shares trade in green after seven straight days of losses
Medtronic: A Great Business, But With Low Growth
Medtronic’s diverse portfolio faces financial growth concerns. Learn why MDT stock is a HOLD, offering stability but limited growth in the short term.
China Courts Apple, Pfizer, Eli Lilly Amid US Pressure, Vice Premier Says Beijing 'Will Continue To Improve The Business Environment'
On Sunday, Chinese Vice Premier He Lifeng met with top executives from Apple Inc. (NASDAQ: AAPL), Pfizer Inc. (NYSE: PFE), Mastercard Inc. (NYSE: MA), Eli Lilly and Co. (NYSE: LLY), Cargill , and ...
Notable healthcare headlines for the week: Pfizer, Sanofi, Sarepta Therapeutics and Medtronic in focus
Looking At Medtronic's Recent Unusual Options Activity
High-rolling investors have positioned themselves bullish on Medtronic (NYSE: MDT), and it's important for retail traders to take note. \This activity came to our attention today through Benzinga's t...
This Senator Just Sold Up To $500K In PepsiCo Stock
A report on March 19, 2025 shows that Senator Tina Smith from Minnesota sale stock in PepsiCo (NASDAQ: PEP), valued between $200,002 and $500,000. According to the March filing, the transaction occur...
Medtronic: Strength In Cardiac Ablation Solutions, Upgrade To Buy
Upgraded Medtronic to a ‘Buy' rating with a fair value of $105 per share, driven by strong growth in Cardiac Ablation Solutions and TAVR markets. Medtronic reported 4.1% organic revenue growth and 6.2...
FDA classifies recall of Medtronic embolization devices as 'most serious'
The U.S. Food and Drug Administration on Tuesday classified the recall of Medtronic's embolization device as "most serious", following reports of the deaths of four patients.
Dividend Kings Of The Future
A list of 9 companies that may reach Dividend King status in the near future. These companies span various sectors and offer investors a wide range of dividend growth rates and yields. A few of these ...
Medtronic slips after FDA notice on product recall
Medtronic (MDT) Announces Transition of Principal Accounting Officer
Medtronic (MDT) Announces Transition of Principal Accounting Officer
The Big 3: KO, MDT, LHX
Stability is Kenny Polcari's theme when it comes to today's Big 3. He explains why Cola-Cola (KO), Medtronic (MDT) and L3Harris (LHX) are undervalued names with quality.
CGS Transforms Workplace Training with Cicero, a New AI-Driven, Customizable Roleplay Platform
NEW YORK, March 10, 2025 (GLOBE NEWSWIRE) -- CGS Immersive™, the leader in enterprise learning that is modernizing training and development with AI and XR technologies, today introduced Cicero™, a hyp...
Medtronic PLC (MDT) Announces Promising Two-Year Results from SMART Trial
Medtronic PLC (MDT) Announces Promising Two-Year Results from SMART Trial
SMART Trial two-year data continues to demonstrate superior valve performance for Evolut TAVR™ system in small annulus patients
CRT 2025 Late Breaking Science features largest head-to-head randomized control TAVR trial to primarily enroll women using the two most widely used global TAVR devices GALWAY, Ireland and WASHINGTON ,...
Medtronic announces cash dividend for fourth quarter of fiscal year 2025
GALWAY, Ireland , March 6, 2025 /PRNewswire/ -- The board of directors of Medtronic plc (NYSE: MDT) on Thursday, March 6, 2025, approved the company's cash dividend for the fourth quarter of fiscal ye...